Barclays’s Pactiv Evergreen Inc. Common stock PTVE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-60,596
| Closed | -$1.09M | – | 5666 |
|
|
2025
Q1 | $1.09M | Sell |
60,596
-41,805
| -41% | -$743K | ﹤0.01% | 3056 |
|
|
2024
Q4 | $1.79M | Buy |
102,401
+38,868
| +61% | +$526K | ﹤0.01% | 2970 |
|
|
2024
Q3 | $731K | Sell |
63,533
-76,767
| -55% | -$881K | ﹤0.01% | 3553 |
|
|
2024
Q2 | $1.59M | Sell |
140,300
-125,791
| -47% | -$1.67M | ﹤0.01% | 2300 |
|
|
2024
Q1 | $3.81M | Buy |
266,091
+141,602
| +114% | +$2.01M | ﹤0.01% | 2046 |
|
|
2023
Q4 | $1.71M | Buy |
124,489
+84,925
| +215% | +$894K | ﹤0.01% | 3037 |
|
|
2023
Q3 | $322K | Sell |
39,564
-12,209
| -24% | -$99.8K | ﹤0.01% | 3058 |
|
|
2023
Q2 | $392K | Buy |
51,773
+29,822
| +136% | +$228K | ﹤0.01% | 2902 |
|
|
2023
Q1 | $176K | Buy |
21,951
+10,344
| +89% | +$106K | ﹤0.01% | 3866 |
|
|
2022
Q4 | $132K | Buy |
11,607
+9,251
| +393% | +$101K | ﹤0.01% | 4065 |
|
|
2022
Q3 | $21K | Buy |
2,356
+187
| +9% | +$1.94K | ﹤0.01% | 4053 |
|
|
2022
Q2 | $22K | Sell |
2,169
-5,020
| -70% | -$50.5K | ﹤0.01% | 4364 |
|
|
2022
Q1 | $73K | Buy |
+7,189
| New | +$76.5K | ﹤0.01% | 3934 |
|
Barclays's PTVE Position: Q2 2025 in Review
Barclays sold out of Pactiv Evergreen Inc. Common stock (PTVE) in Q2 2025, closing a stake of 60,596 shares — an estimated $1.09M sold.
Barclays first reported a position in PTVE in Q1 2022 and held it in 13 quarters. The position peaked at $3.81M in Q1 2024. 0 funds tracked by Wall St. Rank hold PTVE as of Q2 2025.
- Barclays reported no remaining Pactiv Evergreen Inc. Common stock position as of Q2 2025 after selling out during the quarter.
- Barclays sold 60,596 Pactiv Evergreen Inc. Common stock shares in Q2 2025, an estimated $1.09M.
- Barclays first reported a position in Pactiv Evergreen Inc. Common stock in Q1 2022 and held it in 13 quarters.
- Barclays's Pactiv Evergreen Inc. Common stock position peaked at $3.81M in Q1 2024.
- 0 funds tracked by Wall St. Rank held Pactiv Evergreen Inc. Common stock as of Q2 2025.
Based on Barclays's 13F filing for Q2 2025, filed 13 Aug 2025.